The Genetics Podcast by Sano Genetics

369 - EP 263: Bringing the first cardiovascular gene editing therapy to patients with Sek Kathiresan of Eli Lilly

Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com

More episodes

369 - EP 263: Bringing the first cardiovascular gene editing therapy to patients with Sek Kathiresan of Eli Lilly

Thu, 29 Oct 2026
368 - EP 262: The genetic drivers of hemochromatosis, drug response, and multimorbidity with Luke Pilling of the University of Exeter

Thu, 22 Oct 2026
367 - EP 261: Inside the virtual biotech staffed by AI agents with James Zou of Stanford University

Thu, 15 Oct 2026
366 - EP 260: How AI is reshaping genomics, disease prediction, and biosecurity with Jeffrey Barrett of the University of Helsinki

Thu, 08 Oct 2026
365 - EP 259: A patient community driving awareness and research for Danon disease with Jenny Hsieh of the Danon Foundation

Thu, 01 Oct 2026
364 - EP 258: The mutations hiding in healthy tissues with Inigo Martincorena of the Wellcome Sanger Institute

Thu, 24 Sep 2026
363 - EP 257: Managing hereditary cancer risk and medical uncertainty with Marleah Dean Kruzel of the University of South Florida

Thu, 17 Sep 2026
362 - EP 256: Cutting through the AI hype in drug discovery with Dave Hallett of Recursion

Thu, 10 Sep 2026
361 - EP 255: Turning long-read sequencing into a routine part of clinical care with Danny Miller of the University of Washington

Thu, 03 Sep 2026
360 - EP 254: Triangulating genetic evidence and dodging bias to pick winning drug targets with Brent Richards of 5 Prime Sciences

Thu, 27 Aug 2026
359 - EP 253: The genetics of brain size, growth, and aging with Andrew Jackson of the University of Edinburgh

Thu, 20 Aug 2026
358 - EP 252: The diagnosis that became a mission to cure rare disease: Advancing genetic medicine using AI with Stevie Ringel of Nome

Thu, 13 Aug 2026
357 - EP 251: Cracking the delivery barrier in genetic medicine with Jagesh Shah of Mirai Bio

Thu, 06 Aug 2026
356 - EP 250: Redefining rare disease realities with Sharon Terry of the Genetic Alliance [Re-run]

Thu, 30 Jul 2026
355 - EP 249: Building the world's most detailed genetic map of inflammatory bowel disease with Carl Anderson of the Wellcome Sanger Institute

Thu, 23 Jul 2026
354 - EP 248: The blood mutations rewriting cardiovascular risk: Clonal hematopoiesis and polygenic risk with Pradeep Natarajan of Massachusetts General Hospital

Thu, 16 Jul 2026
353 - EP 247: Why neurons accumulate mutations like clockwork: Somatic mosaicism and neurodegeneration with Christopher Walsh of Boston Children's Hospital

Thu, 09 Jul 2026
352 - EP 246: Turning a fatal diagnosis into a cure strategy: Accelerating C9orf72 ALS research with Yentli Soto Albrecht of CureC9

Thu, 02 Jul 2026
351 - EP 245: Developing targeted therapies for ALS with Eric Green of Trace Neuroscience [Re-run]

Thu, 25 Jun 2026
350 - EP 244: Building the first n-of-1 ASO: The new frontier of rare disease with Timothy Yu of Boston Children’s Hospital

Thu, 18 Jun 2026
349 - EP 243: How BD² is using genetics and deep phenotyping to transform bipolar research with Cara Altimus and Ben Neale

Thu, 11 Jun 2026
348 - EP 242: Connecting dementia research, policy, and patient communities with Angela Bradshaw of Alzheimer Europe [Re-Run]

Thu, 04 Jun 2026
347 - EP 241: The hard-won lessons behind Encoded Therapeutics’ Dravet syndrome gene therapy with Salvador Rico [Re-run]

Thu, 28 May 2026
346 - EP 240: Hijacking DNA repair machinery to treat Huntington’s disease with Vincent Dion of the UKDRI

Thu, 21 May 2026
345 - EP 239: What long-read sequencing reveals about Alzheimer’s and ALS with Paul Valdmanis of the University of Washington

Thu, 14 May 2026
344 - EP 238: Uncovering epistatic interactions in complex disease with machine learning with Bin Yu of UC Berkeley

Thu, 07 May 2026
343 - EP 237: How genetics and environment shape neurodegeneration in Alzheimer's and Parkinson's with Sarah Marzi of King’s College London

Thu, 30 Apr 2026
342 - EP 236: Fixing access and design in rare disease drug development: Insights from experts and patient advocates

Thu, 23 Apr 2026
341 - EP 235: Inside Alzheimer’s disease: Blood biomarkers and predicting symptoms with Suzanne Schindler of Washington University

Thu, 16 Apr 2026
340 - EP 234: Inside rare disease trial operations: The role of CROs in an evolving landscape with Derek Ansel of Worldwide Clinical Trials

Thu, 09 Apr 2026
339 - EP 233: Unlocking early detection in liver disease with data and genetics with Tim Jobson of Predictive Health Intelligence

Thu, 02 Apr 2026
338 - EP 232: How ethics and law shape reproductive technology and AI in medicine with Glenn Cohen of Harvard Law School

Thu, 26 Mar 2026
337 - EP 231: From polygenic scores to AI-driven medicine with Andrea Ganna of the Institute for Molecular Medicine Finland

Thu, 19 Mar 2026
336 - EP 230: From short reads to long reads in clinical genomics with Anna Lindstrand of Karolinska Institute

Thu, 12 Mar 2026
335 - EP 229: Turning personal tragedy into a movement for preventive genetics with Matthew Goldstein of jscreen

Thu, 05 Mar 2026
334 - EP 228: What genomes reveal about Epstein–Barr virus and human disease with Ryan Dhindsa and Caleb Lareau

Thu, 26 Feb 2026
333 - EP 227: Discovering a new neurodevelopmental syndrome in the non-coding genome with Nicky Whiffin of the University of Oxford

Thu, 19 Feb 2026
332 - EP 226: Scaling AAV gene therapy: Engineering delivery, safety, and cost with David Dismuke of Forge Biologics and Steven Gray of UT Southwestern

Thu, 12 Feb 2026
331 - EP 225: Lessons from 20 years of building ocular gene therapies with Daniel Chung of Beacon Therapeutics

Thu, 05 Feb 2026
330 - EP 224: Genomic newborn screening in Australia: From pilot studies to population-scale programs with Zornitza Stark of the University of Melbourne

Thu, 29 Jan 2026
329 - EP 223: Live at JPM: Rewriting disease with next-generation genetic medicines with Michelle Werner of Alltrna and Mike Severino of Tessera Therapeutics

Thu, 22 Jan 2026
328 - EP 222: From genetic risk to gene editing in heart failure with Travis Hinson of the Jackson Laboratory and University of Connecticut

Thu, 15 Jan 2026
327 - EP 221: How to build a woolly mammoth: Ancient DNA and de-extinction with Beth Shapiro of Colossal Biosciences

Thu, 08 Jan 2026
326 - EP 220: Turning human brain physiology into RNA medicines with Graham Dempsey of Quiver Bioscience

Tue, 30 Dec 2025
325 - EP 219: A global effort to decode frontotemporal dementia with Arabella Bouzigues of GENFI

Tue, 23 Dec 2025
324 - EP 218: Cardiovascular genomics and the future of preventing heart failure with Krishna Aragam of the Cleveland Clinic

Thu, 18 Dec 2025
323 - EP 217: Building a genomic passport for every family: Insights from tech leader and rare disease parent Lisa Gurry of GeneDx

Thu, 11 Dec 2025
322 - EP 216: Four decades of advancing Duchenne research with Jeffrey Chamberlain of University of Washington

Thu, 04 Dec 2025
321 - EP 215: Vectorized RNAi and the next frontier of gene silencing with Rachel Salzman of Armatus Bio

Thu, 27 Nov 2025
320 - EP 214: Innovating large-scale and sustainable genomics with Slavé Petrovski of AstraZeneca

Thu, 20 Nov 2025

Show more episodes

More podcasts

More international podcasts

Find your radio station